European Journal of Vascular & Endovascular Surgery
Volume 39, Issue 6 , Pages 726-730 , June 2010

CT Angiography Followed by Endovascular Intervention for Acute Superior Mesenteric Artery Occlusion does not Increase Risk of Contrast-Induced Renal Failure

  • S. Acosta

      Affiliations

    • Vascular Center, Malmö University Hospital, 205 02 Malmö, Sweden
    • Corresponding Author InformationCorresponding author. Fax: +46 4033 8097.
    • ,
  • S. Björnsson

      Affiliations

    • Vascular Center, Malmö University Hospital, 205 02 Malmö, Sweden
    • ,
  • O. Ekberg

      Affiliations

    • Department of Radiology, Malmö University Hospital, 205 02 Malmö, Sweden
    • ,
  • T. Resch

      Affiliations

    • Vascular Center, Malmö University Hospital, 205 02 Malmö, Sweden

Received 5 January 2010 ,Accepted 24 January 2010.

References 

  1. Wadman M, Block T, Ekberg O, Elmståhl S, Syk I, Acosta S. Impact of MDCT with intravenous contrast on the survival in patients with acute superior mesenteric artery occlusion. Emerg Radiol 2010 (In Press).
  2. Acosta S, Sonesson B, Resch T. Endovascular therapeutic approaches for acute superior mesenteric artery occlusion. Cardiovasc Intervent Radiol. 2009;32:896–905
  3. Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol. 2008;49:646–657
  4. Grubb A, Nyman U, Björk J, Lindström U, Rippe B, Sterner G, et al. Simple Cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan–Barratt prediction equations for children. Clin Chem. 2005;51:1420–1431
  5. Nyman U, Almen T, Aspelin P, Hellström M, Kristiansson M, Sterner G. Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol. 2005;46:830–842
  6. Katzberg R, Barrett B. Risk of contrast-induced nephropathy with the intravenous administration of iodinated contrast media. Radiology. 2007;243:622–628
  7. Acosta S, Lindblad B, Zdanowski Z. Predictors for outcome after open and endovascular repair of ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2007;33:277–284
  8. Katzberg RW, Lamba R. Contrast-induced nephropathy after intravenous administration – fact or fiction?. Radiol Clin North Am. 2009;47:789–800
  9. Oleinik A, Romero JM, Schwab K, Lev MH, Jhawar N, Delgado JE, et al. CT angiography for intracerebral hemorrhage does not increase risk of nephropathy. Stroke. 2009;40:2393–2397
  10. Thomsen H, Morcos S. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT – A pooled analysis of two randomized trials. Eur Radiol. 2009;19:891–897
  11. Kondo H, Kanematsu M, Goshima S, Tomita Y, Miyoshi T, Atsushi H, et al. Abdominal multidetector CT in patients with varying body fat percentages: estimation of optimal contrast material dose. Radiology. 2008;249:872–877
  12. Esteban JM, Alonso A, Cervera V, Martinez V. One-molar gadolinium chelate (gadobutrol) as a contrast agent for CT angiography of the thoracic and abdominal aorta. Eur Radiol. 2007;17:2394–2400
  13. Sam AD, Morasch MD, Collins J, Song G, Chen R, Pereles FS. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg. 2003;2003(38):313–318
  14. Elmståhl B, Nyman U, Leander P, Chai CM, Frennby B, Almén T. Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs. Acad Radiol. 2004;2004(11):1219–1228

PII: S1078-5884(10)00053-5

doi: 10.1016/j.ejvs.2010.01.017

European Journal of Vascular & Endovascular Surgery
Volume 39, Issue 6 , Pages 726-730 , June 2010

Article Tools

* Image Usage & Resolution